Cardiac metabolomics is a cutting-edge field of study that focuses on the comprehensive analysis of small molecules involved in the metabolic processes within the heart. This discipline plays a crucial role in unraveling the intricate interplay of metabolites, providing valuable insights into the metabolic pathways associated with cardiovascular health and disease. By examining the dynamic changes in metabolite profiles, researchers gain a deeper understanding of the molecular mechanisms underlying cardiac conditions, paving the way for the development of innovative diagnostic tools and targeted therapeutic interventions. Through the lens of metabolomics, scientists aim to decipher the metabolic signatures associated with various cardiac disorders, offering a promising avenue for advancing personalized medicine and enhancing our ability to detect, monitor, and treat cardiovascular diseases with greater precision.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India